The pharma company re-launched Mirabegron extended-release (ER) tablets 25 mg in the United States after the US Court lifted the temporary restraining see more...
Lupin stock plunged 4 percent after the company reported lower-than-expected rise in its Q4 FY24 net profit, dragged by a spike in raw material costs. see more...
the global pharma company has recorded consolidated net profit at rs 359.4 crore for the fourth quarter of financial year 2024, growing 52.3 percent o see more...
Results are coming tomorrow after market hours. Not sure if they have been postponed by a day or they were scheduled for 7th May only but now they are see more...
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL